Pseudoexfoliation syndrome and its antioxidative protection deficiency as risk factors for age-related cataract

European Journal of Ophthalmology

Volumn 16, Issue 2, 2006, Pages 268-273

  Zoric, Lepsa ^a,d   Miric, D ^a   Milenkovic, S ^b   Jovanovic, P ^c   Trajkovic, G ^a  

^a UNIVERSITY OF PRI TINA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF NI   (Serbia)

^d NONE   (Serbia)

Author keywords

Antioxidative protection; Cataract; Oxidative stress; Pseudoexfoliation syndrome

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; GLUTATHIONE; MALONALDEHYDE; PEROXIDASE; THIOL DERIVATIVE;

AGED; AGING; ANTIOXIDANT ACTIVITY; AQUEOUS HUMOR; ARTICLE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CATALYSIS; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTENSION; LENS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PSEUDOEXFOLIATION; RISK FACTOR;

EID: 33745013911     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600212     Document Type: Article

References (51)

1. Hazzard WR. Geriatric medicine. In: Harrison's Principles of Internal Medicine. Vol. I. New York: McGraw Hill 1987; 447-50.
2. Christen WG, Glynn RJ, Hennekens CH. Antioxidants and age-related eye diseases. Current and future perspectives. Ann Epidemiol 1996; 6: 60-6.
3. Ringvold A. Corneal endothelial involvement in pseudoexfoliation syndrome. Arch Ophthalmol 1994; 112: 297-8.
4. Naumann GO, Schlotzer-Schrehardt UM, Kuchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestation. Ophthalmology 1998; 105: 951-68.
5. Johnson DH. The exfoliation syndrome - A continuing challenge. In: Albert & Jakobiec Principles and Practice of Ophthalmology, Vol. 3. Philadelphia: WB Saunders, 1994; 1400-13.
6. Janciauskiene S, Krakau T. Alzheimer's peptide and serine protease inhibitors in glaucoma and exfoliation syndrome. Doc Ophthalmol 2003; 106: 215-23.
7. Ringvold A. On the occurrence of pseudo-exfoliation material in extrabulbar tissue from patients with pseudo-exfoliation syndrome of the eye. Acta Ophthalmol 1972; 8: 394-9.
8. Ringvold A. On the occurrence of pseudo-exfoliation material in extrabulbar tissue from patients with pseudo-exfoliation syndrome of the eye. Acta Ophthalmol (Copenh) 1973; 52: 411-8.
9. Schlotzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110: 1752-6.
10. Streeten BW, Li ZY, Wallace RN, Eagle RC, Keshgegian AA. Pseudoexfoliative fibrilopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992; 110: 1757-62.
11. Uusitalo M, Kivela T. The HNK-1 carbohydrate epitope in the eye: basic science and functional implications. Prog Retin Eye Res 2001; 20: 1-28.
12. Cartaganis SP, Georgakopoulos CD, Assouti M, et al. Changes in HNK-1 epitope and collagen type IX in the aqueous humour of patients with pseudoexfoliation syndrome. Curr Eye Res 2004; 28: 5-10.
13. Schlotzer-Schrehardt U, Kortje KH, Erb C. Energy-filtering transmission electron microscopy (EFTEM) in the elemental analysis of pseudoexfoliative material. Curr Eye Res 2001; 22: 154-62.
14. Zoric L, Zoric D. Exfoliation syndrome in our patients with age-related cataract. Program and abstract book. 2nd International Glaucoma Symposium; Jerusalem, Israel, Kenes, 1998; 168-9.
15. McCorwick DB. Vitamins. In: Tetz NW. Textbook of Clinical Chemistry. Philadelphia: WB Saunders, 1986; 927.
16. Straus B. Medical Biochemistry. Zagreb: JUMENA, 1988:96-7.
17. Dacie JV, Lewis SM. Estimation of reduced glutathione (GSH). In: Practical Hematology. Edinburgh: Churchill Livingstone, 1985; 168-80.
18. Koroljuk MA, Ivanova LI, Maiorova JG, Tokarev VE. Method of determination of catalase activity. Lab Delo 1988; 1: 16-9.
19. Majkic Singh N. Clinical Enzymology. Beograd; AID Praktikum; 1993: 67-72.
20. Ledwazyw A, Michalak B, Stepien A, Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta 1986; 155: 275-84.
21. Yalaz M, Othman I, Nas K, Eroglu A, Homurhu D. The frequency of pseudoexfoliation syndrome in eastern Mediterranean area of Turkey. Acta Ophthalmol (Copenh) 1992; 70: 209-13.
22. Cashwell LF, Shields MB. Exfoliation syndrome. Prevalence in a southeastern US population. Arch Ophthalmol 1988; 106: 335-6.
23. Teshome T, Regassa K. Prevalence of pseudoexfoliation syndrome in Ethiopian patients scheduled for cataract surgery. Acta Ophthalmol Scand 2004; 82: 254-8.
24. Puska P, Tarkkanen A. Exfoliation syndrome as a risk factor for cataract development: five-year follow-up of lens opacities in exfoliation syndrome. J Cataract Refract Surg 2001; 27: 1992-8.
25. Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001; 56: 265-315.
26. Sainz Gomez C, Moreno-Montanes J, Escudero Berasategui JM, et al. Prevalence and risk factors of pseudoexfoliation syndrome in institutionalized geriatric patients in Navarra. Arch Soc Esp Oftalmol 2003; 78: 383-8.
27. Goth L. No catalase isoenzymes in serum. Clin Chem 1987; 33: 2302-3.
28. Djordjevic BV, Cosic V, Pavlovic D, et al. Does captopril change oxidative stress in puromycin aminonucleoside nephropathy? Renal Fail 2000; 22: 535-44.
29. Casado A, de La Torre R, Lopez-Fernandez E. Antioxidant enzyme levels in red blood cells from cataract patients. Gerontology 2001; 47: 186-8.
30. Spector A, Wang GM, Wang RR, Garner WH, Moll H. The prevention of cataract caused by oxidative stress in cultured rat lenses. I. H2O2 and photochemically induced cataract. Curr Eye Res 1993; 12: 163-79.
31. Ozmen B, Ozmen D, Erkin E, et al. Lens superoxide dismutase and catalase activities in diabetic cataract. Clin Biochem 2002; 35: 69-72.
32. Psilas KG, Stefaniotou MJ, Aspiotis MB. Pseudoexfoliation syndrome and diabetes mellitus. Acta Ophthalmol (Copenh) 1991; 69: 664-6.
33. Konstas AG, Tsatsos I, Kardasopoulos A, Bufidis T, Maskaleris G. Preoperative features of patients with exfoliation glaucoma and primary open-angle glaucoma. The AHEPA study. Acta Ophthalmol Scand 1998; 76: 208-12.
34. phacoemulsification in patients with and without pseudoexfoliation syndrome. J Cataract Refract Surg 2003; 29: 1080-6.
35. Naumann Allingham RR, Loftsdottir M, Gottfredsdottir MS, et al. Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol 2001; 85: 702-7.
36. Sollosu M. Incidence of the uveal pseudoexfoliation syndrome in patients with diabetes mellitus. Oftalmologia 2004; 48: 75-80.
37. Zoric L. Some parameters of the oxidative stress in lens, aqueous humour and serum of patients with diabetes and age-related cataract. Serb Arch Med 2003; 3-4: 142-8.
38. Ozmen D, Ozmen B, Mutaf J, Mentes J, Bayindir O. Lens lipid peroxides and glutathione concentrations in diabetic cataract. Am J Biochem 1977; 34: 190-2.
39. Donma O, Yorulmaz E, Pekel H, Suyugul N. Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients. Curr Eye Res 2002; 25: 9-16.
40. Metelitsyna IP. Metabolic disturbances in blood from patients with senile cataracts accompanied by somatic diseases. Ukr Biokhim Zh 1998; 70: 110-5.
41. Ringvold A, Davanger M. Iris neovascularisation in eyes with pseudoexfoliation syndrome. Br J Ophthalmol 1981; 65: 138-41.
42. Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997; 124: 685-7.
43. Schumacher S, Schlotzer-Schrehardt U, Martus P, Lang W, Naumann GO. Pseudoexfoliation syndrome and aneurisms of the abdominal aorta. Lancet 2001; 357: 359-60.
44. Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol Scand 1997; 75: 266-6.
45. Ritland JS, Egge K, Lydersen S, Juul R, Semb SO. Comparison of survival of exfoliative glaucoma patients and primary open-angle glaucoma patients: impact of acetazolamide use. Acta Ophthalmol Scand 2004; 82: 397-400.
46. Ritland JS, Egge K, Lydersen S, Juul R, Semb SO. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 2004; 82: 401-4.
47. Linner E, Popovic V, Gottfries CG, Jonsson M, Sjogren M, Wallin A. The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type. Acta Ophthalmol Scand 2001; 79: 283-5.
48. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 2000; 129: 83-6.
49. Reniewska B, Mulak M, Misiuk-Hojlo M, Kostus E. Coexistence of Alzheimer's disease with pseudoexfoliation syndrome. Klin Oczna 2004; 106: 107-9.
50. Melov S, Wolf N, Strozyk D, Doctrow SR, Bush AI. Mice transgenic for Alzheimer disease beta amyloid develop lens cataract that are rescued by antioxidant treatment. Free Radic Biol Med 2005; 38: 258-61.
51. Koliakos GG, Konstas AG, Schlotzer-Schrehardt LJ, et al. 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87: 353-6.